Reported Apr 5, 2023 · Ongoing

CRP Immunoturbidimetric reagent. Intended for the quantitative in vitro determination of CRP concentration in serum…

Randox Laboratories

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Randox Laboratories · 515 Industrial Blvd · Kearneysville, WV · 25430-2778

Is this the product you have?

  • CRP Immunoturbidimetric reagent. Intended for the quantitative in vitro determination of CRP
  • concentration in serum Catalogue numberCP3826
Lot codes and dates
  • GTIN05055273201765
  • Batch588434
Amount recalled
2 kits

Where it was sold

Why it was recalled

The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Randox Laboratories recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Data as of Sep 19, 6:19 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.